FDA Drug recall D-181-2013

ABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America Pharmaceutical Inc., Bristol-Myers Squibb NDC 5…

FDA Drug
Class II
terminated
Published 2013-03-13

On 2013-03-13 the FDA classified a Class II recall of ABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America Pharmaceutical Inc., Bristol-Myers Squibb NDC 5… by Bristol Myers Squibb Manufacturing, citing CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged….

Read the official FDA Drug notice

Agency	FDA Drug
Recall number	D-181-2013
Classification	Class II
Status	terminated
Initiated	2012-11-02
Published	2013-03-13
Last updated	2026-09-13 11:51 UTC
Company	Bristol Myers Squibb Manufacturing
Distribution	CA, LA, TN

Product

ABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America Pharmaceutical Inc., Bristol-Myers Squibb NDC 59148-011-35

Reason

CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged and distributed.

Identifiers

ndc	59148-006-13
ndc	59148-006-92
ndc	59148-007-13
ndc	59148-007-35
ndc	59148-007-94
ndc	59148-008-13
ndc	59148-008-35
ndc	59148-008-95
ndc	59148-009-13
ndc	59148-009-35
ndc	59148-009-95
ndc	59148-010-13
ndc	59148-010-35
ndc	59148-011-13
ndc	59148-011-35
code_info	2E69023A, Exp. FEB 28 2015

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-181-2013%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.